Robotimize spotlights KidGo exoskeleton at CPAS Symposium in Singapore

Robotimize Group featured the KidGo exoskeleton from RoboCT at CPAS Symposium 2026 in Singapore, using the event to position assistive technology around daily life, classrooms and home care. The company said the gathering sharpened its focus on clinician-led rehabilitation and cross-disciplinary input from educators, caregivers and allied health professionals.

Why it matters: - Robotimize used the CPAS Symposium 2026 to showcase how the KidGo exoskeleton fits into real-world rehabilitation, not just clinical demonstrations. - The event put educators, caregivers and allied health professionals in the same room, underscoring how assistive technology for children with multiple disabilities depends on input beyond engineering. - The symposium theme, Enriching Journeys, Empowering Lives, aligned with Robotimize's push to support mobility and participation across the lifespan.

What happened: - Robotimize Group took part in CPAS Symposium 2026 at Holiday Inn Atrium in Singapore. - Cerebral Palsy Alliance Singapore organised the symposium. - Robotimize featured the KidGo exoskeleton from RoboCT within its ACE™ portfolio. - The company joined educators, special education teachers, early childhood educators, early interventionists, allied health professionals, caregivers and other industry leaders at the event.

The details: - The symposium focused on empowering the lives of people with multiple disabilities across the lifespan. - The programme included keynotes, panel discussions, hands-on workshops, practice-based sessions and poster presentations. - Sessions covered early intervention, education and the transition into adulthood. - Breakout sessions and a learning journey through the CPAS School gave participants a look at how practice-based strategies and assistive technologies work in a real learning environment. - Robotimize said that setting helped frame technology in terms of classroom routines, therapy sessions and daily family life. - KidGo is an exoskeleton developed by RoboCT for gait training. - KidGo is offered in versions intended for both clinical and home settings. - Robotimize positioned KidGo as support for a developmental stage when movement patterns that affect long-term independence are still forming. - Robotimize presented KidGo within ACE™, its strategic partnerships network that includes technologies from RoboCT, MINATO Medical Science and Von Ardenne Institute. - ACE™ is tied to clinician-led rehabilitation and technology-enabled care pathways. - Robotimize's VivantePlexus™ ecosystem and ACE™ portfolio are designed to support care beyond a single clinical visit. - Robotimize is headquartered in Singapore and focuses on intelligent rehabilitation robotics and digital neurotechnologies. - The company says product availability, indications and use depend on regulatory approvals and local clinical requirements. - More information is available here.

Between the lines: - Robotimize is signaling that adoption of assistive technology depends as much on workflow, caregiving and school routines as on device specifications. - The company is also trying to position its portfolio inside a broader care ecosystem, not as a standalone product sale. - Kerry Guo, Robotimize's founder and CEO, said a device earns its place when it fits the rhythms of daily life, not the reverse. - Zen Koh, Robotimize's scientific advisor, said gait training only works when timed to a developmental window and informed by educators and caregivers as much as engineers.

What's next: - Robotimize said it looks forward to continuing to learn from and support the community that gathered at the symposium. - The company also said it will keep advocating for more pathways to solutions that support people with multiple disabilities across every stage of life. - The symposium format suggests Robotimize will continue seeking venues where educators, clinicians and caregivers can shape how its technologies are used.

The bottom line: - Robotimize used CPAS Symposium 2026 to argue that the value of rehabilitation tech is measured by how well it works in everyday life, not just in clinical settings.